Both SNRPD1 and EFNA5 are members of the ‘HALLMARK G2M CHECKPOINT’ gene set, so they participate in cell proliferation and tumour progression via cell cycle arrest at the G2/M‐phase. The gene discussed is SNRPD1; the disease is neoplasm.